📅 PUBMED DAILY TRIAGE — 2026-10-17 Window: 2026-10-16T09:20:11Z → 2026-10-17T09:20:02Z (CRDT) Topics scanned: 10 | Articles reviewed: 118 | Candidates evaluated: 132 High priority: 0 | Standard: 15 | Low/archive: 0 | Unsolicited finds: 0 Run status: SUCCESS
🔴🟠 HIGH PRIORITY (8+) — Best Finds by Topic
Hematologic malignancies
Hematologic malignancies: No high-priority finds today (best candidate scored 6/10).
CBC-based diagnostics and machine learning in hematology
CBC-based diagnostics and machine learning in hematology: No high-priority finds today (best candidate scored 5/10).
Early cancer detection
Early cancer detection: No high-priority finds today (best candidate scored 5/10).
AI/ML in clinical diagnostics and imaging
AI/ML in clinical diagnostics and imaging: No high-priority finds today (best candidate scored 5/10).
Precision oncology and genomic medicine
Precision oncology and genomic medicine: No high-priority finds today (best candidate scored 7/10).
Novel therapeutics: immunotherapy, CAR-T, targeted therapy
Novel therapeutics: immunotherapy, CAR-T, targeted therapy: No high-priority finds today (best candidate scored 7/10).
Cardiovascular-metabolic: GLP-1, SGLT2, cardiometabolic risk
Cardiovascular-metabolic: GLP-1, SGLT2, cardiometabolic risk: No high-priority finds today (best candidate scored 7/10).
Aging, longevity, and population health
Aging, longevity, and population health: No high-priority finds today (best candidate scored 5/10).
Rare diseases with high unmet need
Rare diseases with high unmet need: No high-priority finds today (best candidate scored 5/10).
Sentinel scan
Sentinel scan: No high-priority finds today (best candidate scored 7/10).
🟢⚪ STANDARD (5-7) — Top by Topic
Hematologic malignancies
PMID:42887726 · External Validation of the CARE-BMT and Modified CARE-BMT Scores for Cardiac Event Prediction After Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia. · 6/10 · Diagnostics PMID:42886051 · Non-Relapse Mortality With Bispecific Antibodies in Hematologic Malignancies: A Dual Systematic Review and Pharmacovigilance Analysis. · 5/10 · Treatment Innovation
CBC-based diagnostics and machine learning in hematology
PMID:42884488 · An Artificial Intelligence Framework for Detection of Leukemia with Comparison Between Segmented and Non-Segmented Images. · 5/10 · Diagnostics PMID:42882864 · Preoperative Systemic Inflammatory Indices as Adjunctive Biomarkers for Malignancy Prediction in Bethesda III (AUS) Thyroid Nodules. · 5/10 · Diagnostics
Early cancer detection
PMID:42885914 · Enhanced detection of bladder cancer using machine learning analysis of routine urinary sediment data. · 5/10 · Early Detection PMID:42881789 · Beyond Screening Populations: Context-Dependent Performance of Lung Cancer Risk Assessment Strategies in a Diagnostically Enriched Cohort. · 5/10 · Early Detection
AI/ML in clinical diagnostics and imaging
PMID:42888053 · Robustness of Nomogram Versus Deep Learning Models for Hepatocarcinoma Grading: Insights From a Bilateral Cross-Center Validation. · 5/10 · Diagnostics
Precision oncology and genomic medicine
PMID:42885310 · Navigating the landscape of targeted therapies for renal cell carcinoma in the era of precision medicine (Review). · 7/10 · Genomics/Precision Medicine
Novel therapeutics: immunotherapy, CAR-T, targeted therapy
PMID:42887596 · Efficacy and safety of camrelizumab plus docetaxel and carboplatin as neoadjuvant therapy for stage II-III triple-negative breast cancer: the HELEN-Trio 011 randomized clinical trial. · 7/10 · Treatment Innovation PMID:42888040 · Prospective phase I study of nivolumab to promote graft-versus-tumour in relapsed or refractory haematological malignancy post allogeneic haematopoietic stem cell transplantation. · 5/10 · Treatment Innovation PMID:42886051 · Non-Relapse Mortality With Bispecific Antibodies in Hematologic Malignancies: A Dual Systematic Review and Pharmacovigilance Analysis. · 5/10 · Treatment Innovation
Cardiovascular-metabolic: GLP-1, SGLT2, cardiometabolic risk
PMID:42885189 · Chios Mastic in Well-Controlled Hypertension: Findings From the HYPER-MASTIC Randomized Controlled Trial. · 7/10 · Prevention PMID:42886876 · Midlife and Late-Life Alzheimer Disease Blood Biomarkers and 11-Year Cognitive Decline. · 5/10 · Prevention
Aging, longevity, and population health
PMID:42886750 · H-HQNN: Hybrid quantum-classical neural network with feature selection by heuristics to predict heart failure. · 5/10 · Diagnostics PMID:42886051 · Non-Relapse Mortality With Bispecific Antibodies in Hematologic Malignancies: A Dual Systematic Review and Pharmacovigilance Analysis. · 5/10 · Treatment Innovation PMID:42885258 · Key Predictors of Cerebral Vasospasm Following Subarachnoid Hemorrhage: A Systematic Review and Meta-Analysis. · 5/10 · Public Health
Rare diseases with high unmet need
PMID:42886896 · Provider Practice and Patient Clinical Follow-Up Among Patients With Spinal Muscular Atrophy (SMA) Linked-Variant. · 5/10 · Drug Development
Sentinel scan
PMID:42885189 · Chios Mastic in Well-Controlled Hypertension: Findings From the HYPER-MASTIC Randomized Controlled Trial. · 7/10 · Prevention
💡 UNSOLICITED FINDS
No retained high-signal out-of-watchlist items.
📊 TODAY'S BREAKDOWN
- By research category: Diagnostics 5, Drug Development 1, Early Detection 2, Genomics/Precision Medicine 1, Prevention 2, Public Health 1, Treatment Innovation 3
- By evidence maturity: Exploratory 3, Validated 12
- By watchlist topic:
- Hematologic malignancies: 15 reviewed / 2 kept / highest 6
- CBC-based diagnostics and machine learning in hematology: 2 reviewed / 2 kept / highest 5
- Early cancer detection: 15 reviewed / 2 kept / highest 5
- AI/ML in clinical diagnostics and imaging: 15 reviewed / 1 kept / highest 5
- Precision oncology and genomic medicine: 15 reviewed / 1 kept / highest 7
- Novel therapeutics: immunotherapy, CAR-T, targeted therapy: 15 reviewed / 3 kept / highest 7
- Cardiovascular-metabolic: GLP-1, SGLT2, cardiometabolic risk: 15 reviewed / 2 kept / highest 7
- Aging, longevity, and population health: 15 reviewed / 3 kept / highest 5
- Rare diseases with high unmet need: 15 reviewed / 1 kept / highest 5
- Sentinel scan: 10 reviewed / 1 kept / highest 7
- By source type: peer_reviewed 15 | preprint 0
- Topics with zero 8+ articles this run: Hematologic malignancies, CBC-based diagnostics and machine learning in hematology, Early cancer detection, AI/ML in clinical diagnostics and imaging, Precision oncology and genomic medicine, Novel therapeutics: immunotherapy, CAR-T, targeted therapy, Cardiovascular-metabolic: GLP-1, SGLT2, cardiometabolic risk, Aging, longevity, and population health, Rare diseases with high unmet need, Sentinel scan
🔧 RUN NOTES
- No window expansion was required because the run returned more than five relevant records.
- Per-topic ESearch selection was capped at 15 candidates; sentinel was capped at 10.
- Full ESummary and EFetch coverage was independently reconciled for every selected PMID.
- Same-date rerun regenerated complete daily coverage; Telegram alert sending was outside this validator-gated attempt.